ArticleFrontiers in medical technology2026
Continuous BP monitoring of ICU Taiwanese patients: training-phase evaluation of oCare™ BP100 according to ISO 81060-3: 2022.
Article in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to conduct a training-phase evaluation of a novel continuous automated non-invasive sphygmomanometer, oCare™ BP100, in intensive care unit (ICU) Taiwanese patients according to ISO 81060-3:2022 in Type T mode. The evaluation included stability testing and blood pressure change tracking. Methods: A total of forty ICU patients were recruited from the National Taiwan University Hospital Hsin-Chu Branch. All enrolled patients had undergone unilateral radial artery catheterization in the forearm as part of routine clinical care. The catheter was connected to Philips patient monitors (Models: IntelliVue MX800 and X2) to obtain invasive blood pressure measurements for calibration purposes. Each subject underwent simultaneous monitoring with oCare™ BP100 sensors placed on the fingers of both hands. Paired measurements of the same side were further processed and followed ISO 81060-3:2022, for the defined Type T blood pressure monitor, the well-established stability method and the blood pressure change method were implemented and analyzed. Results: The present study belongs to the training phase and therefore the study was not carried out completely according to the ISO 81060-3:2022 protocol, e.g., the distribution of gender and the eligible subject in BP change test not fulfilled. For all 6 analysis periods, for the corrected standard deviations of SBP, DBP, and MAP parameter defined ISO target thresholds (A) s Conclusion: The present study demonstrated that a training-phase evaluation of Type T mode continuous automated non-invasive sphygmomanometer repeated SBP, DBP, and MAP measurement of oCare™ BP100 in Type T mode are stable across various analysis periods and patients. oCare™ BP100 in Type T Mode can track blood pressure changes in ICU patients during different activities. Even with the absence of females in the sex ratio and an insufficient number of participants in the blood pressure change test, the exploratory study still showed training-phase results that were within ISO target thresholds, full ISO validation remains to be completed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.